Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mitochondrial dynamics and biogenesis indicators may serve as potential biomarkers for diagnosis of myasthenia gravis

24 Feb 2022

Abstract excerpt

Due to challenges in diagnosing myasthenia gravis (MG), identifying novel diagnostic biomarkers for this disease is essential. Mitochondria are key organelles that regulate multiple physiological functions, such as energy production, cell proliferation and cell death. In the present study, Mfn1/2, Opa1, Drp1, Fis1, AMPK, PGC-1α, NRF-1 and TFAM were compared between patients with MG and healthy subjects to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Myasthenia Gravis and Thymoma
Share to Parkinson's Disease and Spinal Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35340870
DOI: 10.3892/etm.2022.11236

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mitochondrial dynamics and biogenesis indicators may serve as potential biomarkers for diagnosis of myasthenia gravisPMID 35340870Read ↗

Mitochondrial dysfunction in myasthenia gravis: Exploring directions for future immunotherapy? A reviewSemantic proximity Read ↗

Mitochondrial autophagy-related gene signatures associated with myasthenia gravis diagnosis and immunitySemantic proximity Read ↗

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.Semantic proximity Read ↗

Myasthenia gravis and related disorders: Pathology and molecular pathogenesisSemantic proximity Read ↗

Mitochondrial proteins contribute to the pathogenesis of myasthenia gravis.Semantic proximity Read ↗

Myasthenia gravis: The pharmacological basis of traditional Chinese medicine for its clinical applicationSemantic proximity Read ↗

Construction of a TF–miRNA–gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravisSemantic proximity Read ↗

Comprehensive analysis of GDF15 as a biomarker in primary mitochondrial myopathiesSemantic proximity Read ↗

Idiopathic chronic fatigue in older adults is linked to impaired mitochondrial content and biogenesis signaling in skeletal muscleSemantic proximity Read ↗

Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders.Semantic proximity Read ↗

A Retrospective Longitudinal Cohort Study of The Clinical Burden in Myasthenia GravisSemantic proximity Read ↗

Non-coding RNA and its network in the pathogenesis of Myasthenia GravisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.